Novo Nordisk A/S vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
6.1
Hold
Overall
6.2
Hold
Quality
Health
Growth
Valuation
Sentiment
NVO
High-quality business with 61% return on equity and 33% profit margins.
⚠ revenue declining 8% year-over-year.
UNH
82% of 28 covering analysts rate it Buy or Strong Buy.
⚠ limited growth momentum.
Analyst Consensus
HOLD
Target $46.66 (+9.6%)
12 analysts
BUY
Target $387.27 (+4.6%)
26 analysts
Fundamentals
NVO
UNH
11.8×
Trailing P/E
28.0×
12.4×
Forward P/E
17.8×
33.1%
Profit Margin
2.7%
82.4%
Gross Margin
18.8%
60.7%
ROE
12.2%
-7.6%
Revenue Growth
2.0%
-4.7%
Earnings Growth
0.7%
0.27
Beta
0.41
—
Price / Book
—
$188.8B
Market Cap
$336.3B
$35 – $81
52-Week Range
$235 – $412
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.